SEC Has Opened 12 Debt Securities-Related Investigations

The U.S. Securities and Exchange Commission has opened 12 enforcement investigations into matters surrounding collateralized debt obligations (CDO), the agency's leader told a Congressional panel.

SEC Chairman Christopher Cox, in responding to questions about whether the CDO market needs more transparency, said that the agency's enforcement division has launched a dozen probes into "issues such as this."

"There is now a commonality of interest between banking regulators and securities regulators when it comes to safety and soundness" issues, Cox added in testimony at the House Financial Services Committee hearing.

A collateralized debt obligation or CDO is a security backed by a pool of loans or other fixed income securities.

Cox did not identify the names of any companies involved in the investigations, or elaborate on the nature of the probes or whether they involved subprime mortgage CDOs.

Cox was asked about CDOs by Rep. Carolyn Maloney, a New York Democrat who expressed concern that these financial securities might threaten the overall health of the U.S. economy. She also expressed similar concerns about collateralized loan obligations.

Bear Stearns, the fifth-largest U.S. investment bank, said on Friday it would loan up to $3.2 billion to the High-Grade Structured Credit Strategies Fund, which suffered big losses from investments in the repackaged subprime mortgage loan market when homeowner defaults started rising.

Concerns have been raised about other funds that invested in CDOs involving similar securities linked to subprime mortgages.


  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video